Icalziss

Calcium chloride dihydrate, the active ingredient in Icalziss, is a calcium supplement presented as an intravenous solution for extracorporeal use. It supplies calcium ions to restore plasma calcium levels and supports physiological functions such as cardiac contractility and neuromuscular transmission in patients requiring electrolyte replenishment.

GNH USA supplies Icalziss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU GMP standards and provides reliable logistics for clinical and acute care settings. Clients benefit from consistent quality, regulatory compliance, and responsive technical support.

Icalziss is used to correct calcium deficits and support cardiac and neuromuscular function in various clinical settings.

- Hypocalcemia: restores low plasma calcium concentrations to normal levels. - Cardiac surgery: provides calcium to maintain myocardial contractility and stabilize rhythm during peri‑operative management. - Massive transfusion: replenishes calcium bound by citrate in stored blood products, preventing hypocalcemia. - Hyperkalemia adjunct therapy: transiently protects cardiac cells while other measures lower serum potassium.

Calcium chloride IV may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Irritation at the infusion site - Transient hypotension - Nausea or vomiting - Headache

Serious or Rare Side Effects: - Cardiac arrhythmias, including ventricular tachycardia - Severe hypercalcemia leading to renal impairment - Tissue necrosis if the solution extravasates - Anaphylactic or severe allergic reactions - Seizures

When using Icalziss, clinicians should observe several precautionary measures to ensure safe administration.

- Baseline assessment: measure serum calcium and electrolytes before infusion. - Renal function: adjust or monitor dosing in patients with renal impairment. - Cardiac monitoring: observe rhythm and blood pressure during and after infusion. - Infusion rate: avoid rapid administration; deliver over the recommended time. - Hypercalcemia risk: discontinue or reduce dose if serum calcium rises above therapeutic range. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Calcium chloride can affect the activity of several medicines; awareness of key interactions helps prevent complications.

Major Interactions (Avoid): - Digoxin: increased risk of arrhythmias due to altered calcium levels. - Calcium channel blockers: additive hypotensive effect. - Barium sulfate contrast agents: calcium may precipitate, reducing imaging quality.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase calcium loss, requiring closer monitoring. - ACE inhibitors or ARBs: monitor blood pressure and renal function. - Magnesium supplements: combined hypercalcemia risk.